Attached files
file | filename |
---|---|
EX-21.1 - EX-21.1 - Urovant Sciences Ltd. | d587760dex211.htm |
EX-10.10 - EX-10.10 - Urovant Sciences Ltd. | d587760dex1010.htm |
EX-10.9 - EX-10.9 - Urovant Sciences Ltd. | d587760dex109.htm |
EX-10.8 - EX-10.8 - Urovant Sciences Ltd. | d587760dex108.htm |
EX-10.7 - EX-10.7 - Urovant Sciences Ltd. | d587760dex107.htm |
EX-10.6 - EX-10.6 - Urovant Sciences Ltd. | d587760dex106.htm |
EX-10.5 - EX-10.5 - Urovant Sciences Ltd. | d587760dex105.htm |
EX-10.4 - EX-10.4 - Urovant Sciences Ltd. | d587760dex104.htm |
EX-10.3 - EX-10.3 - Urovant Sciences Ltd. | d587760dex103.htm |
EX-10.2 - EX-10.2 - Urovant Sciences Ltd. | d587760dex102.htm |
EX-10.1 - EX-10.1 - Urovant Sciences Ltd. | d587760dex101.htm |
EX-3.3 - EX-3.3 - Urovant Sciences Ltd. | d587760dex33.htm |
EX-3.2 - EX-3.2 - Urovant Sciences Ltd. | d587760dex32.htm |
EX-3.1 - EX-3.1 - Urovant Sciences Ltd. | d587760dex31.htm |
S-1 - S-1 - Urovant Sciences Ltd. | d587760ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption Experts and to the use of our report dated June 4, 2018, in the Registration Statement on Form S-1 and related Prospectus of Urovant Sciences Ltd. for the registration of its common shares.
/s/ Ernst & Young LLP
Iselin, New Jersey
July 13, 2018